These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30809797)

  • 21. Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.
    Anoop P; Sankpal S; Stiller C; Tewari S; Lancaster DL; Khabra K; Taj MM
    Leuk Lymphoma; 2012 Oct; 53(10):1882-8. PubMed ID: 22448922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
    Egan G; Goldman S; Alexander S
    Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry.
    Bhaker P; Das A; Rajwanshi A; Gautam U; Trehan A; Bansal D; Varma N; Srinivasan R
    Cancer Cytopathol; 2015 Sep; 123(9):557-65. PubMed ID: 26243719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoblastic lymphoma.
    Cortelazzo S; Ferreri A; Hoelzer D; Ponzoni M
    Crit Rev Oncol Hematol; 2017 May; 113():304-317. PubMed ID: 28427520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
    Lin P; Jones D; Dorfman DM; Medeiros LJ
    Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
    Sakarou M; Eisele L; Dührsen U; Hüttmann A
    Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review.
    Siegel SE; Stock W; Johnson RH; Advani A; Muffly L; Douer D; Reed D; Lewis M; Freyer DR; Shah B; Luger S; Hayes-Lattin B; Jaboin JJ; Coccia PF; DeAngelo DJ; Seibel N; Bleyer A
    JAMA Oncol; 2018 May; 4(5):725-734. PubMed ID: 29450465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J; Schrappe M; Ludwig WD; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
    Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in the Management of Acute Lymphoblastic Leukaemia.
    Hodby KA; Marks DI
    Curr Treat Options Oncol; 2020 Feb; 21(3):23. PubMed ID: 32095902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Fukano R; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kobayashi R; Horibe K; Tsurusawa M
    Pediatr Blood Cancer; 2016 Mar; 63(3):451-7. PubMed ID: 26585702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of children and adolescents with lymphoblastic lymphoma.
    Oliveira MC; Sampaio KC; Oliveira AC; Santos AD; Castro LP; Viana MB
    Rev Assoc Med Bras (1992); 2016; 62(1):59-64. PubMed ID: 27008495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].
    Sun XF; Jiang WQ; Liu DG; Xia ZJ; Huang HQ; Zhang L; Li YH; Zhou ZM; Zhen ZJ; Xia Y; He YJ; Guan ZZ
    Ai Zheng; 2004 Dec; 23(12):1687-91. PubMed ID: 15601561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
    Sekimizu M; Sunami S; Nakazawa A; Hayashi Y; Okimoto Y; Saito AM; Horibe K; Tsurusawa M; Mori T
    Br J Haematol; 2011 Sep; 154(5):612-7. PubMed ID: 21689091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult lymphoblastic lymphoma.
    Portell CA; Sweetenham JW
    Cancer J; 2012; 18(5):432-8. PubMed ID: 23006948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.
    Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y;
    Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
    Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
    Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinical feature and treatment outcome in 42 patients with lymphoblastic lymphoma].
    Lu B; Li Q; Zou DH; Zhao YZ; Qi JY; Xu Y; Qui LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):446-9. PubMed ID: 21678570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
    DeAngelo DJ
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1121-35, vii-viii. PubMed ID: 19825456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.